Arkolith/Insider Trading/ZIVO/Form 4

Yaldoo Laith L

DirectorZivo Bioscience, Inc. (ZIVO) · full profile →Form 4 · filed Oct 17, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 16, 2024Buy(P)3K$15.96$50K533K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 16, 2024Buy(P)313$15.96$5K313

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641073-24-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML